- Home
- OHI vs NBIX Comparison
OHI vs NBIX Comparison
Compare OHI & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OHI
- NBIX
- Stock Information
- Founded
- OHI 1992
- NBIX 1992
- Country
- OHI United States
- NBIX United States
- Employees
- OHI N/A
- NBIX N/A
- Industry
- OHI Real Estate Investment Trusts
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OHI Real Estate
- NBIX Health Care
- Exchange
- OHI Nasdaq
- NBIX Nasdaq
- Market Cap
- OHI 10.8B
- NBIX 12.0B
- IPO Year
- OHI N/A
- NBIX 1996
- Fundamental
- Price
- OHI $36.95
- NBIX $123.02
- Analyst Decision
- OHI Buy
- NBIX Strong Buy
- Analyst Count
- OHI 9
- NBIX 20
- Target Price
- OHI $41.00
- NBIX $163.20
- AVG Volume (30 Days)
- OHI 2.9M
- NBIX 1.6M
- Earning Date
- OHI 05-01-2025
- NBIX 05-05-2025
- Dividend Yield
- OHI 7.24%
- NBIX N/A
- EPS Growth
- OHI 44.22
- NBIX N/A
- EPS
- OHI 1.60
- NBIX 2.96
- Revenue
- OHI $1,084,876,000.00
- NBIX $2,412,600,000.00
- Revenue This Year
- OHI $12.61
- NBIX $15.99
- Revenue Next Year
- OHI $4.81
- NBIX $14.93
- P/E Ratio
- OHI $23.13
- NBIX $41.60
- Revenue Growth
- OHI 11.29
- NBIX 21.73
- 52 Week Low
- OHI $30.94
- NBIX $84.23
- 52 Week High
- OHI $44.42
- NBIX $157.98
- Technical
- Relative Strength Index (RSI)
- OHI 50.43
- NBIX 62.85
- Support Level
- OHI $35.88
- NBIX $117.59
- Resistance Level
- OHI $36.95
- NBIX $125.63
- Average True Range (ATR)
- OHI 0.63
- NBIX 2.98
- MACD
- OHI 0.07
- NBIX -0.02
- Stochastic Oscillator
- OHI 65.92
- NBIX 72.90
About OHI Omega Healthcare Investors Inc.
Omega Healthcare Investors Inc is a healthcare facility real estate investment trust that invests in the United States real estate markets. Omega's portfolio focuses on long-term healthcare facilities. Omega has one reportable segment consisting of investments in healthcare-related real estate properties located in the United States and the United Kingdom. Its core business is to provide financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities (SNFs), assisted living facilities (ALFs), and to a lesser extent, independent living facilities (ILFs), rehabilitation and acute care facilities (specialty facilities) and medical office buildings (MOBs).
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.